However, this study has certain limitations, including the lack of in vivo studies on NDC1 in pancreatic cancer and the specific molecular biological mechanism of NDC1 regulation of pancreatic cancer, etc. Further studies are still needed to guide clinical diagnosis and treatment in the future. Here, NDC1 is linked to familial pancreatic carcinoma.